Thalassemia Society of Mauritius - TSM

31/10/2026

Thalassemia is an inherited blood disorder characterized by abnormal hemoglobin production, leading to a shortage of healthy red blood cells and severe anemia.

Treatment typically requires lifelong management, including regular blood transfusions and chelation therapy to remove excess iron from the body.

27/10/2026

One Drop of Humanity. Give blood. Save lives! 🩸

Join Emtel and the Thalassemia Society of Mauritius for our Blood Drive, and help save lives through the gift of blood!

🗓️ Wednesday 28 October
⏰ 09:30 - 15:15
📍 EmtelWorld, Ebene Cybercity

Every drop counts. Be a hero! ❤️

24/10/2026

COMING SOON | A NEW GUIDE FROM TIF

What does my diagnosis mean? Why do I need this test? What should I ask during my next appointment?

Living with brings questions at every stage.
Information you can understand can help you feel more confident asking them.

That is the starting point for TIF’s upcoming guide: ‘Thalassaemia Explained – What I Need to Know’.

Created for people with thalassaemia, their families and caregivers, it brings TIF’s renowned closer to the people it is meant to support, helping them better understand their condition and take part in conversations about their care.

📖 Here’s your first look at the cover.
📅 Publication is expected in mid-November 2026.

Stay connected with TIF as we reveal more!

19/10/2026

19/10/2026

TIF’s Annual Report 2025 is here! 📘

Explore a year of education, advocacy and collaboration, driven by a shared commitment to better care for every person living with .

Among this year's highlights:

🔹 Publishing the 5th edition of the 'Guidelines for the Management of Transfusion-Dependent β-Thalassaemia', bringing international expertise and the latest evidence into .

🔹 Awarding TIF certification to nine centres, supporting standards of care, professional development and international collaboration.

🔹 Convening the first 'TIF Pan-American Conference on Thalassaemia and Other Haemoglobin Disorders', bringing together 340 attendees from 20 countries.

🔹 Holding our first for , strengthening nurses’ vital role in delivering comprehensive, compassionate care.

Patients’ needs and experiences remain at the heart of this work, shaping our priorities and our determination to make accessible to all.

📖 Read our Annual Report 2025 and explore the work behind our shared mission. Link in the comments. 👇

19/10/2026

🚨 TIF is delighted to announce that the second edition of the 'Guidelines for the Emergency Management of Thalassaemia and Sickle Cell Disease' has now been published.

Thoroughly revised, updated and significantly expanded, this new edition builds on TIF’s pioneering 2012 publication while extending its scope to encompass , alongside .

At its heart lies the vital objective to help respond swiftly, safely and confidently when a person living with a haemoglobin disorder requires . The guide provides a practical and accessible framework for recognising potentially serious signs, symptoms and complications; undertaking appropriate initial assessments and investigations; initiating urgent management; and identifying when specialist involvement or escalation of care is required.

This landmark publication is the product of an extensive international collaboration, bringing together a distinguished multidisciplinary group of editors, authors and contributors whose collective expertise spans , and related fields.

TIF extends its sincere appreciation to every expert who contributed to this major undertaking.

A much-needed resource is now ready to support emergency , , , , and healthcare teams worldwide.

🔗 Access and download the full publication through the link in the first comment below.

16/10/2026